Overview
Primary ciliary dyskinesia (PCD), also known as immotile cilia syndrome or Kartagener syndrome (when accompanied by situs inversus), is a rare inherited disorder affecting the structure and/or function of motile cilia — tiny hair-like projections that line the airways, middle ear, reproductive tract, and embryonic node. Defective ciliary motility leads to impaired mucociliary clearance in the respiratory tract, resulting in chronic and recurrent upper and lower respiratory infections. The hallmark clinical features include neonatal respiratory distress, chronic wet cough beginning in early childhood, recurrent sinusitis, chronic otitis media with effusion often leading to hearing impairment, and progressive bronchiectasis. Approximately 50% of individuals with PCD have situs inversus totalis (mirror-image reversal of internal organs), and a smaller subset may have heterotaxy with associated congenital heart defects, reflecting the role of nodal cilia in establishing left-right body asymmetry during embryonic development. PCD is caused by pathogenic variants in genes encoding ciliary structural proteins, assembly factors, or regulatory components. Over 50 causative genes have been identified to date, including DNAI1, DNAH5, DNAH11, CCDC39, CCDC40, and many others. The diagnosis is established through a combination of clinical suspicion, nasal nitric oxide measurement (characteristically very low in PCD), high-speed video microscopy of ciliary beat pattern, transmission electron microscopy of ciliary ultrastructure, immunofluorescence staining of ciliary proteins, and genetic testing. No single test is sufficient for diagnosis, and a multi-test approach is recommended. There is currently no cure for PCD, and no approved therapies specifically target the underlying ciliary defect. Management is largely supportive and borrows from cystic fibrosis care paradigms, focusing on aggressive airway clearance techniques (chest physiotherapy, exercise), prompt treatment of respiratory infections with antibiotics, and regular monitoring of lung function. Hearing aids may be needed for conductive hearing loss, and surgical interventions such as tympanostomy tubes or sinus surgery may be considered in selected cases. Fertility may be affected in both males (due to dysmotile sperm) and females (due to impaired ciliary function in the fallopian tubes), though assisted reproductive technologies can be successful. Early diagnosis and proactive management are essential to slow the progression of lung disease and preserve quality of life.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
10 eventsUniversity of Wisconsin, Madison
University of Thessaly — NA
Clinique Sainte Clotilde — NA
Thomas Aagaard Rasmussen — PHASE1
Corcept Therapeutics — PHASE1, PHASE2
University of Missouri-Columbia — NA
Seoul National University Hospital
Instituto Nacional de Enfermedades Respiratorias — NA
Association Francaise pour la Recherche Thermale — NA
University Hospital Southampton NHS Foundation Trust
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Primary ciliary dyskinesia.
17 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Rare Disease Specialist
Treatment Centers
8 centersCHU de Caen
📍 Caen
Hôpital de la Timone
📍 Marseille
Stanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
Travel Grants
No travel grants are currently matched to Primary ciliary dyskinesia.
Community
No community posts yet. Be the first to share your experience with Primary ciliary dyskinesia.
Start the conversation →Latest news about Primary ciliary dyskinesia
1 articlesCaregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Primary ciliary dyskinesia
What is Primary ciliary dyskinesia?
Primary ciliary dyskinesia (PCD), also known as immotile cilia syndrome or Kartagener syndrome (when accompanied by situs inversus), is a rare inherited disorder affecting the structure and/or function of motile cilia — tiny hair-like projections that line the airways, middle ear, reproductive tract, and embryonic node. Defective ciliary motility leads to impaired mucociliary clearance in the respiratory tract, resulting in chronic and recurrent upper and lower respiratory infections. The hallmark clinical features include neonatal respiratory distress, chronic wet cough beginning in early chi
How is Primary ciliary dyskinesia inherited?
Primary ciliary dyskinesia follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Primary ciliary dyskinesia typically begin?
Typical onset of Primary ciliary dyskinesia is neonatal. Age of onset can vary across affected individuals.
Are there clinical trials for Primary ciliary dyskinesia?
Yes — 17 recruiting clinical trials are currently listed for Primary ciliary dyskinesia on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Primary ciliary dyskinesia?
25 specialists and care centers treating Primary ciliary dyskinesia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.